key: cord-0923311-8ibrsg9j
authors: Cimolai, Nevio
title: Features of enteric disease from human coronaviruses: Implications for COVID‐19
date: 2020-06-05
journal: J Med Virol
DOI: 10.1002/jmv.26066
sha: 5f578106f0617f6b3c9f4123098afef0a914eb16
doc_id: 923311
cord_uid: 8ibrsg9j

Coronaviruses have long been studied in both human and veterinary fields. Whereas the initial detection of endemic human respiratory coronaviruses was problematic, detection of these and newly discovered human coronaviruses has been greatly facilitated with major advances in the laboratory. Nevertheless, technological factors can affect the accuracy and timeliness of virus detection. Many human coronaviruses can be variably found in stool samples. All human coronaviruses have been variably associated with symptoms of gastroenteritis. Coronaviruses can occasionally be cultured from enteric specimens, but most detection is accomplished with genetic amplification technologies. Excretion of viral RNA in stool can extend for a prolonged period. Culture‐positive stool samples have been found to exceed a fourteen day period after onset of infection for some coronaviruses. Virus can also sometimes be cultured from patients' respiratory samples during the late incubation period. Relatively asymptomatic patients may excrete virus. Both viable and nonviable virus can be found in the immediate environment of the patient, the health care worker, and less often the public. These lessons from the past study of animal and human coronaviruses can be extended to presumptions for severe acute respiratory syndrome coronavirus 2. Already, the early reports from the coronavirus disease‐2019 pandemic are confirming some concerns. These data have the cumulative potential to cause us to rethink some current and common public health and infection control strategies.

largely on serological assessments of antigenicity and crossreactions. Whereas human coronaviruses appeared initially limited to a few serologically distinct clusters, a larger spectrum became known in the veterinary field in short order. Before SARS-CoV-2, six human coronavirus groups were established in human infection represented by the designations OC43, 229E, NL63, HKU1, SARS-CoV, and MERS-CoV. 2, 3 Although antigenic and genetic distinctions prevail, these viruses nevertheless share many structural and behavioral characteristics that rightfully justify their inclusion in a common family of viruses, the Coronaviridae. Four genus clusters have been proposed for coronaviruses generally, but the human coronaviruses, including the newly recognized SARS-CoV-2, all belong to two so designated Alphacoronavirus and Betacoronavirus. The origin and evolution of these pathogens has now been studied considerably, and there is good reason to believe that animal origins and recombination events have been instrumental in giving rise to the human coronaviruses that we find today. 4 Four of these viruses were believed to have been endemic to humans-OC43, 229E, NL63, and HKU1; the remaining three (SARS-CoV, MERS-CoV, and SARS-CoV-2) putatively represent a more contemporary presence. The

Betacoronavirus lineages can be further subdivided by comparative genomics; lineage A includes OC43 and HKU1, lineage B includes SARS-CoV and SAR-CoV-2, and lineage C includes MERS-CoV. 4, 5 Despite several differences in genome, phenotype, cellular attachment, or intracellular multiplication, there are equally many commonalities that are apparent thus giving justification to comparative discussions. One such commonality as we discuss herein is the ability for these viruses to be associated with enteric disease. As becomes apparent from this review, this aspect of pathogenesis may lead us to rethink the standard approaches taken thus far if not only provide for some stimulating and/or sobering thought.

As is evident from the plethora of scientific and medical publications that are arising for COVID-19, approaches to the detection, disease management, and prevention were very much dependent on lessons learned from the severe acute respiratory syndrome (SARS) and

Middle East respiratory syndrome (MERS) epidemics. 6, 7 The spread of SARS seems to have been terminated during 1 year, while MERS infections continued over a much longer period and are yet of lingering concern for relapse. The latter gives credence to the fact that, while there may be commonalities which suffice to assist us in these regards, there are nevertheless some virus-virus distinctions which must be considered.

Emerging data for COVID-19 have already corroborated or added to this concept sufficiently to cause some concern. [8] [9] [10] [11] [12] [13] [14] [15] The "incubation period" is typically less than 1 week, but any such calculation is bound by a confidence interval of earlier or later presentation. Lauer et al 11 have estimated that the late 97.5% confidence outlier can be as long as 15 to 16 days. Extending their calculation to a higher percentile of confidence leads to an estimate that nearly one in 100 patients will have an incubation longer than 14 days. The actual practice seems to corroborate the latter. Wang et al 9 provide clinical findings from the China experience that the incubation can occasionally extend up to 24 days. Backer et al, 14 using data from travelers abroad that have returned from China, found a 97.5% confidence interval extending to 11.1 days, but a 99% confidence extending to possibly 17 to 32 days depending on the method of evaluation. The latter is also consistent with the transmission dynamics shown by Li et al. 16 Qiu et al 17 projected an incubation period of up to 32 days. Thus, while the majority of patients become ill in less than 2 weeks, outliers to this belief will inevitably occur when the population being affected is quite large as is occurring worldwide in several countries. These outliers therefore have the potential to promote viral transmission when it may not seem likely. A role for both respiratory and enteric reservoirs in this transmission could have relevance for prevention and control.

Typically, the "incubation period" is used to refer to the time from contact to the time of first clinical illness manifestation. As for SARS and MERS, and now documented for patients with COVID-19, some patients have been shown to harbor the virus in a relatively asymptomatic state. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] This may especially be true for infected children. 22, 26 It is of further concern when applicable to health care workers. 27 Tang et al 8 describe an asymptomatic child with prolonged SARS-CoV-2 genome excretion in the stool as detected with nucleic acid amplification technology. Respiratory samples from the child were negative by the same technique. Wang et al 9 report that many of their patients were relatively asymptomatic. In the asymptomatic state, therefore, the typical application of "incubation period" takes on another dimension, that is, a time from exposure to the time of first positive diagnostic sample in the asymptomatic state. The latter will again have the potential to complicate control measures. These concerns may very well explain why some have proposed that SARS-CoV-2 could be transmitted during the incubation period in a presymptomatic state. 18, 20, [34] [35] [36] [37] [38] [39] [40] [41] As for other human coronaviruses, SARS-CoV-2 can be found in both respiratory and stool (and urine and blood) patient samples. 10, 12, [42] [43] [44] Thus, the potential patient sample source for transmission is likely to be more than simply respiratory. The enteric reservoir is further supported by symptoms of enteritis or abdominal complaint in some patients. 10, 13, 45, 46 Contamination of the patient environment can be widespread. 15 Furthermore, there is no good evidence at this time to prove that other animal enteric coronaviruses cause human disease. The latter is rather remarkable given the potential human contact with such viruses in animal husbandry in the least.

Other early studies examined a possible link between OC43 and neonatal calf diarrhea coronavirus (NCDCV). [50] [51] [52] There were some commonalities in antigenic makeup, and both human and bovine antisera reacted with each virus although the two were not identical. 50, 52 OC43 also shared immunological cross-reactivity with an unknown human enteric coronavirus isolate, and the distinction from NCDCV was apparent. 51,53 Some degree of immunological cross-reactivity was also found for 229E and some animal coronaviruses that were associated with diarrhea in their hosts. 54 Further isolates of human enteric coronavirus (not then designated specific lineages) were found to be serologically distinct from OC43, 229E, mouse hepatitis virus-A59 (a murine coronavirus), and Breda virus (a bovine enteric torovirus). 55 There were no further reports eventually characterizing these at the molecular level. The advent of molecular biology has since considerably changed the manner in which these viruses could now be compared with good precision. 4 Such technology has since defined likely sources and vectors in nature for SARS-CoV and MERS-CoV. 2,3

Knowledge of filterable albeit seemingly noncultivable agents in feces that could cause transmissible diarrhea in humans led in part to the use of electron microscopy (EM) for the detection of viruses in stool samples. Although initially and highly focused on rotavirus and enteric adenovirus, several presumed viral particles were identified in the stool of ill patients. 56 In most laboratories, the coronaviruses constituted a considerable minority of such EM findings for humans.

In the veterinary field, coronaviruses were found by EM in enteric specimens of many animals. 57 Reports of the EM findings of coronavirus suggested that the putative pathogen(s) could be identified in outbreak settings of diarrhea. 55, [58] [59] [60] [61] [62] [63] [64] [65] Studies from Argentina and Saudi Arabia respectively found the virus structure in 1.1% and 6% of samples from children with diarrhea. 61, 66 The coronavirus morphotype was also found in outbreaks among neonates during manifestations of neonatal necrotizing enterocolitis. 55, 65, 67 Patients with HIV infection, including some with a characteristic "wasting syndrome,"

were also found to have coronaviruses in stool samples. [68] [69] [70] [71] Corroborative evidence for some of these findings was proposed by González et al 72 who found presumed viral antigen in stool specimens by enzyme immunoassays. Clarke et al, 73 who were among the leaders in this field at the time, suggested that enteric excretion of such viral coronavirus-like particles could continue for months.

By 1980, a review of international proceedings on the subject had already acknowledged that coronaviruses could cause enteric disease. 74 Up to 70% of presumed enteric viral particles could be coronaviruses. 75 Confirmatory tests were generally unavailable at the time of the above publications, although immune electron microscopy from some studies suggested an infectious link given the use of convalescent patient sera.

Given the requirement of EM and given the nature of coronavirus morphology sought in such endeavors, there was some speculation that the laboratory findings could be over-represented. 76, 77 For some geographic regions, the frequency of EM-coronavirus morphotypes were equally found in symptomatic and control patients. 73, [78] [79] [80] [81] In these regards, some investigators believed that coronaviruses could not be confirmed as enteric pathogens even by 2003. 82 The discovery of Torovirus and its possible relationship to human disease also complicated the differentiation of viruses that could pose with the same morphological appearance to some observers.

The use of genetic amplification technologies has added considerably to the finding of coronaviruses from clinical samples, and this progression has allowed for considerable subsequent study. Of note, however, nearly all such studies of endemic coronaviruses have not used culture confirmation or secondary corroborative test methods.

One collaborative group determined the presence of coronavirus with direct immunofluorescence of respiratory samples. 83 In cohorts assessed for the presence of coronaviruses in respiratory and/or stool samples in the context of respiratory disease, these viruses have been found in variable frequencies. [84] [85] [86] [87] [88] [89] Depending on the study, gastrointestinal symptoms (variably diarrhea, abdominal pain, and/or emesis) proved to be common. [83] [84] [85] [86] 88, 89 Likewise, the viruses have also been found in cohorts of patients who have presented purely with CIMOLAI | 3 gastrointestinal symptoms. 84, [90] [91] [92] One study found an equal proportion of patients with gastrointestinal symptoms in comparing groups that have been found to harbor either OC43 or NL63 in respiratory specimens. 85 Others found a higher frequency of gastroenteritis among patients with NL63 in respiratory specimens versus those whose sample was negative for a respiratory virus generally. 88 A significant association of gastrointestinal disease with respiratory coronavirus detection was found in

France, but few of the patients had these viruses detected in stool. 89 Coronaviruses were found more commonly in symptomatic gastroenteritis than controls. 91 Nevertheless, there are mitigating findings from others which would be taken together to counter the above data and that might lead one to conclude that these endemic coronaviruses are not veritable enteric pathogens. [92] [93] [94] In Arizona, USA, patients with severe coronavirus-associated lower respiratory disease did not present with diarrhea. 94 Among children with acute gastroenteritis, the frequency of coronavirus isolation was similar for those with disease and controls. 92 In some studies, the detection of coronavirus in stools was commonly associated with the finding of another but commonly recognized viral enteric pathogen. 86, [90] [91] [92] [93] In one such study, multiple simultaneous enteric viral pathogens (at times up to four) were said to have been codetected. 90 The latter seriously raises the issue of the validity of the assays and of the need to have some form of confirmatory test. The latter would be applicable to the detection of coronaviruses let alone any other pathogen purely detected by realtime amplification processes.

The diversity of the endemic coronavirus group so understood at this time also raises the question as to whether any specific one may be more pathogenic than another, and whether any one may be more likely to cause gastrointestinal symptoms. For OC43, several studies had found enteric coronaviruses with some antigenic relationship. 51, 53, 95 Among patients with acute OC43-related respiratory disease, over one-half of the patients has gastrointestinal symptoms. 96 A smaller proportion of patients with the same virus had enteric symptoms in another study. 97 When NL63 was isolated from patients with either respiratory or febrile illnesses, nearly one-third had diarrhea or abdominal pain. 98,99 HKU-1 was also commonly associated with intestinal illnesses albeit mostly in common with acute respiratory infection. [100] [101] [102] [103] Some have suggested that the frequency of gastrointestinal symptoms was no different for comparisons of patients with OC43, NL63, and HKU-1. 86 The cumulative evidence in this field finds that endemic human coronaviruses can be found in patients with respiratory disease who have gastrointestinal symptoms or those with purely gastrointestinal disease. There is controversy as to the extent of the role for such illness.

Gastrointestinal symptoms mainly in the form of diarrhea were common (~33%-73%) in patients with SARS-CoV infection. [104] [105] [106] [107] Although this manifestation may have been uncommon at the first day of presentation, these symptoms became apparent at a variable time later. 107 In "atypical" presentations, a patient may have had no apparent respiratory symptoms while yet suffering from fever and/or diarrhea. 108 When using RNA detection methods, stool samples were commonly positive at a later peak timing than respiratory samples, but not as late as urine reactive samples. 107, 109 Any such sampling that depends on amplification technology must bear in mind the diagnostic pitfalls inherent, and repeat sampling increases the positive and hence diagnostic yields. 110 SARS patients diagnosed by one or several laboratory methods had a positive stool screen for the viral genome in approximately 28% to 78% of patients. 105, 111, 112 The majority of these were found in the period of 9 to 14 days after the onset of clinical infection. 105, 107, 111, 113 By the third week after onset of infection, viral RNA could be amplified in almost 2/3 of patients. 107 Detection in stool samples continued for up to 10 weeks. 106, 112, 114, 115 Prolonged excretion detected with genetic amplification correlated with increasing patient comorbidities. 114 Increased viral load quantitated in stool samples correlated with greater likely for the patient to suffer with diarrhea. 105 Most of the latter studies were not simultaneously assessing viral culture for pathogen viability.

Whereas the virus could be obtained from some stools by culture, the vast majority were culture-negative by the end of the first week. 113 Indeed most stools were culture-negative. 105, [115] [116] [117] Despite the latter, however, stools yielding virus in tissue culture have been found 14 to 21 days after onset of disease. 115, 116 Cultures for both respiratory and urine samples can extend beyond 14 days. 113 For purposes of hospital infection control and general prevention elsewhere, the above findings suggest that some patients remain infectious by at least that route for a longer period of time than is commonly thought. In experimental settings, SARS-CoV can survive in stool samples for 3 hours to 4 days, and the viability is greater when the sample has an alkaline pH. 118 In contrast, virus can remain viable for up to 1 week at room temperature in respiratory secretions and up to 4 weeks when refrigerated. 118 These findings are relevant to one outbreak in which it was believed that a sewer backup facilitated some spread. 117 Although reverse transcriptasepolymerase chain reaction positive, culture-negative sewage was found in such a context, the inoculation of sewage with live virus showed that viability could be found for 2 days when stored at room temperature but up to 14 days when refrigerated. 119 All such assessments must be viewed with caution since even spiked samples of stool, urine, blood, and respiratory secretions may not yield fully positive amplification tests. 109 As for proof of enteric disease, some pointed studies have examined tissue pathology from biopsy or autopsy. 104, 120, 121 Both intestinal mucosal epithelium and lymphoid tissue were shown to have the virus by in situ hybridization. 120 Coronavirus-like particles were also visualized in the latter enteric epithelial tissue when viewed by electron microscopy. Other autopsy-based review found that SARS-CoV could infect multiple tissues which included intestinal mucosa, lymphoid tissue, and circulating lymphocytes. 121 There is further corroboration in the finding of virus by culture from both small and large intestines whether from colonoscopy biopsy or postmortem tissue. 106 In the latter study, over one-quarter of the patients manifested diarrhea, several had findings of virus in the stool, and eight patients presented with fever and/or diarrhea in the absence of respiratory symptoms.

Gastrointestinal symptoms, especially diarrhea, are common in MERS-CoV infections and occur in up to at least one-third of patients. [122] [123] [124] [125] [126] What has been somewhat more important in this context, however, is that asymptomatic or relatively minor infections occur in a considerable number of people who test positive with genetic amplification technologies. [127] [128] [129] One review proposed that some 12% to 25% of identified MERS-CoV infections are asymptomatic. 130 These findings also need to be couched in the context of potential test fallibility for a variety of reasons. 131 From nasopharyngeal samples, both viral RNA and culture-viable MERS-CoV can be found in patients past 14 days. 124, 132 Viral RNA can be detected for up to 27 to 47 days (average 14 days) in stool samples. 124, 127, 133 Some 14% to 50% of MERS infections will shed viral RNA in stool. 124, 133 Even those stool samples with the highest viral RNA load proved to be culture-negative in one study. 133 Two studies that examined stool for viable virus were unsuccessful, but these reports included only a total of eleven stools tested. 124,133

The finding of SARS-CoV-2 RNA in stool samples by amplification is now accepted widely. 134, 135 Early data also suggests that a substantial portion of patients suffer gastrointestinal complaints. 21 

The environmental viability and susceptibility to various conditions and cleaning agents have been reviewed. [158] [159] [160] As surrogates, various animal-sourced coronaviruses have been studied. [161] [162] [163] [164] Porcine transmissible gastroenteritis virus survives on a variety of health care equipment for at least 4 hours and up to 24 hours. 162 Mouse hepatitis virus can survive in both water and sewage fluid and can be inactivated by many disinfectants and antiseptics. 163, 164 Porcine epidemic diarrhea virus can be found in air samples and over a prolonged distance downwind. 161 OC43 can survive on hospital surfaces for hours and has been found on airport commodities. 165, 166 229E can also survive on hospital surfaces and remained infectious on public surface materials for days. 165, 167 SARS-CoV was found in patient rooms, nursing stations, emergency department, and public service areas of a hospital by RNA amplification. 168 None of the latter could be confirmed with culture. CIMOLAI | 5

In another study, SARS-CoV was more resilient to decontamination than 229E under experimental conditions. 169 In the context of MERS-CoV, sources in the patient room, medical equipment, and the isolation anteroom all bore evidence of the virus by both detection of viral genetic amplification and culture. 132 Environmental contamination with SARS-CoV-2 is also becoming quite apparent. [170] [171] [172] [173] [174] Although there are differences for specific surfaces more at risk among these reports, there is consistency that environmental spread is a significant problem. The latter may include personal protective equipment. 173 Most such studies, however, have used viral RNA detection. The finding of viral RNA in municipal wastewater has been cited. 175 

All human coronaviruses can be found in stool samples, but the role of the endemic coronaviruses in diarrheal disease, while suggestive, requires further corroboration. Nevertheless, all human coronaviruses have been variably associated with symptoms of gastroenteritis. Coronaviruses can be cultured from enteric specimens, but most detection is accomplished with genetic amplification technologies. Excretion of viral RNA in stool can extend for a prolonged period. 176 Culture-positive stool samples have been found to exceed a 14 day period after onset of infection. Virus can also be cultured from patients during the late incubation period. Relatively asymptomatic patients may excrete virus. Both viable and nonviable virus can be found in the immediate environment of the patient, the health care worker, and less often the public. As we are finding now early with COVID-19 infections, many of these past realizations are repeating themselves (Table 1 ).

In addition to the above concerns and their direct application to nosocomial infection control epidemiology, there is direct relevance to gastrointestinal endoscopy, and several pragmatic guides have emerged early. [177] [178] [179] [180] [181] [182] [183] Whereas infection control practices are groomed for many circumstances on the basis of likelihoods or risk management, we are finding that the presence of, persistence of, and resilience of the human coronaviruses is somewhat beyond initial and some past expectations.

Accordingly, we may need to rethink detection and protection timings for the purposes of infection control especially in circumstances where spread is lesser tolerated. [184] [185] [186] There is no doubt that the currently and 

The author declares that there is no conflict of interest.

http://orcid.org/0000-0003-2743-0556 

The prevalence, origin, and prevention of six human coronaviruses

Hosts and sources of endemic human coronaviruses

Origin and evolution of pathogenic coronaviruses

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study

SARS and MERS: recent insights into emerging coronaviruses

Detection of novel coronavirus by RT-PCR in stool specimen from asymptomatic child

Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures

Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests

The incubation period of coronavirus disease 2010 (COVID-19) from publicly reported confirmed cases: estimation and application

Epidemiologic features and clinical course of patients with SARS-CoV-2 in Singapore

Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia

Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travelers from Wuhan, China

Air, surface environmental, and personal perspective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China

Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility

The isolation period should be longer: lesson from a child infected with SARS-CoV-2 in Chongqing, China

Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China

Multi-omics evaluation of gastrointestinal and other clinical characteristics of SARS-CoV-2 and COVID-19

Clinical and transmission dynamics characteristics of 406 children with coronavirus disease 2019 in China: a review

Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection

Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing

Preparation for the quarantine of the Diamond Princess cruise ship for COVID-19 in Japan: study design

Clinical features of pediatric patients with coronavirus disease (COVID-19)

Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission

The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou

Severe acute respiratory syndrome coronavirus 2 infection among returnees to Japan from Wuhan, China

Detection of SARS-CoV-2 among residents and staff members of an independent and assisted living community for older adults

COVID-19 in a patient with long-term use of glucocorticoids: a study of a familial cluster

The enlightenment from two cases of asymptomatic infection with SARS-CoV-2: is it safe after 14 days of incubation?

Severe acute respiratory syndrome coronavirus 2 shedding by travelers

A familial cluster of infection associated with the novel 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period

Transmission of 2019-nCoV infection from asymptomatic contact in Germany

Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic

Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data

SARS-CoV-2 transmission from presymptomatic meeting attendee

Serial interval of COVID-19 among publicly reported confirmed cases

Transmission of COVID-19 in the terminal stage of incubation period: a familial cluster

Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 19-23 years outside Wuhan and characteristics of young patients with COVID-19: a prospective contact-tracing study

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

Virological assessment of hospitalized patients with COVID-2019

Clinical and virological data of the first cases of COVID-19 in Europe: a case series

Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: a retrospective single center analysis

Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?

Emerging coronaviruses: genome, structure, replication, and pathogenesis

Neutralization of infectious bronchitis virus by human sera

Detection of antibody to avian viruses in human populations

Prevalence of antibody to human coronaviruses 229E, OC43 and neonatal calf diarrhea coronavirus (NCDCV) in patients of northern Italy

Coronaviruses and gastroenteritis: evidence of antigenic relatedness between human enteric coronavirus strains and human coronavirus OC43

Antigenic and biological relationships between human coronavirus OC43 and neonatal calf diarrhoea coronavirus

Antigenic relatedness of human enteric coronavirus strains to human coronavirus OC43: a preliminary report

Relatedness of rabbit coronavirus to other coronaviruses

Isolation and propagation of a human enteric coronavirus

Viruses in the stools

Rotavirus and coronavirus associated diarrhoea in domestic animals

Coronavirus particles in faeces from patients with gastroenteritis

Coronaviruses in training centre for intellectually retarded

Coronavirus-like particles in adults in Melbourne, Australia

Detection of coronaviruses in children with acute gastroenteritis in Maddina, Saudi Arabia

Coronavirus particles in faeces from patients with gastroenteritis

Further studies of 35-40 nm virus-like particles associated with outbreaks of acute gastroenteritis

Human enteric coronaviruses

Association of coronavirus infection with neonatal necrotizing enterocolitis

Rotavirus infection in children hospitalized for diarrhoea in Argentina

Pleomorphic, enveloped, virus-like particles associated with gastrointestinal illness in neonates

Opportunistic infections with coronavirus-like particles in patients infected with the human immunodeficiency virus? Zentrabl Bakteriol

Stool viruses, coinfections, and diarrhea in HIV-infected patients. Berlin Diarrhea/Wasting Syndrome Study Group

Detection of coronavirus-like particles in homosexual men with acquired immunodeficiency and related lymphadenopathy syndrome

Enteric viral infections as a cause of diarrhoea in the acquired immunodeficiency syndrome

Rotavirus and coronavirus outbreak: etiology of annual diarrhea in Costa Rican children

The human enteric coronaviruses

Coronavirus come of age

An eightyear study of the viral agents of acute gastroenteritis in humans: ultrastructural observations and seasonal distribution with a major emphasis on coronavirus-like particles

Are coronavirus-like particles seen in diarrhoea stools really viruses?

Recognition of human enteric coronaviruses by electron microscopy

Coronavirus-like particles and other agents in the faeces of children in Efate, Vanuatu

Human-enteric-coronaviruslike particles (CVLP) with different epidemiological characteristics

Coronavirus-like particles in aboriginals and non-aboriginals in Western Australia

Rotavirus, coronavirus-like particles, bacteria and parasites in Central Australia

Viruses causing gastroenteritis

Surveillance of community-acquired viral infections due to respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995

The role of human coronavirus in children hospitalized for acute bronchiolitis, acute gastroenteritis, and febrile seizures: a 2-year prospective study

Detection of four human coronaviruses in respiratory infections in children: a one-year study in Colorado

Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France

Clinical and virological factors associated with gastrointestinal symptoms in patients with acute respiratory infection: a two-year prospective study in general practice medicine

Human coronavirus NL63 in children: epidemiology, disease spectrum, and genetic diversity

Coronavirus infection and hospitalizations for acute respiratory illness in young children

Molecular detection of gastrointestinal viral infections in hospitalized patients

Detection of human coronaviruses in simultaneously collected stool samples and nasopharyngeal swabs from hospitalized children with acute gastroenteritis

Detection of human coronaviruses in children with acute gastroenteritis

Commonly circulating human coronaviruses do not have a significant role in the etiology of gastrointestinal infections in hospitalized children

Surveillance for severe acute respiratory infections in Southern Arizona

Human enteric coronaviruses: antigenic relatedness to human coronavirus OC43 and possible etiologic role in viral gastroenteritis

An outbreak of coronavirus OC43 respiratory infection in Normandy, France

Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou

Human coronavirus NL63, France

Isolation of coronavirus NL63 from blood from children in rural Haiti: phylogenetic similarities with recent isolates from Malaysia

Detection of the new human coronavirus HKU1: a report of 6 cases

Human coronavirus-HKU1 infection among adults in Cleveland

Species-specific clinical characteristics of human coronavirus infection among otherwise healthy adolescents and adults. Influenza Other Respir Viruses

Human coronaviruses are uncommon in patients with gastrointestinal illness

Viral replication in the nasopharynx is associated with diarrhea in patients with severe acute respiratory syndrome

Viral loads in clinical specimens and SARS manifestations

Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic

Laboratory diagnosis of SARS

Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus

Viral shedding patterns of coronavirus in patients with probable severe acute respiratory specimens

Detection for severe acute respiratory syndrome (SARS) coronavirus RNA in stools of SARS patients

Laboratory diagnosis of SARS

Long-term SARS coronavirus excretion from patient cohort

Detection of SARS coronavirus in patients with suspected SARS

SARS-associated coronavirus transmission, United States

Excretion and detection of SARS coronavirus and its nucleic acid from digestive system

Survival of severe acute respiratory syndrome coronavirus

Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan hospital and the 309th Hospital of the Chinese People's Liberation Army

Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases

Multiple organ infection and the pathogenesis of SARS

Viral shedding and environmental cleaning in Middle East respiratory syndrome coronavirus infection

Hospital outbreak of Middle East respiratory syndrome coronavirus

Middle East respiratory syndrome coronavirus infection dynamics and antibody responses among clinically diverse patients, Saudi Arabia

Risk factors for Middle East respiratory syndrome coronavirus infection among healthcare personnel

Middle East respiratory syndrome

Healthcare worker exposure to Middle East respiratory syndrome coronavirus (MERS-CoV): revision of screening strategies urgently needed

A review of asymptomatic and sub-clinical Middle East respiratory syndrome coronavirus infections

Middle East respiratory syndrome coronavirus transmission among health care workers: Implication for infection control

Asymptomatic Middle East respiratory syndrome coronavirus (MERS-CoV) infection: extent and implications for infection control: a systematic review

Proficiency testing for the detection of Middle East respiratory syndrome coronavirus demonstrates global capacity to detect Middle East respiratory syndrome coronavirus

Environmental contamination and viral shedding in MERS patients during MERS-CoV outbreak in South Korea

Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection

Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia

Detection of SARS-CoV-2 by RT-PCR in anal from patients who have recovered from coronavirus disease

Prolonged viral shedding in feces of pediatric patients with coronavirus disease

Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection

Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention, and treatment

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes

Isolation of 2019-nCoV from a stool specimen of a laboratory confirmed case of the coronavirus disease 2019 (COVID019)

Infection of bat and human intestinal organoids by SARS-CoV-2

Replicative capacity of MERS coronavirus in livestock cell lines

Susceptibility of different eukaryotic cell lines to SARScoronavirus

Comparison of the replication of distinct strains of human coronavirus OC43 in organotypic human colon cells (Caco-2) and mouse intestine

Further studies on human enteric coronaviruses

Coronavirus infection in acute lower respiratory tract disease of infants

SARS-CoV-2 productively infects human gut enterocytes

Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus

Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus

2019 novel coronavirus infection and gastrointestinal tract

Expression of SARS-CoV-2 entry molecules ACE2 and TMPRSS2 in the gut of patients with IBD

COVID-19, coronavirus, SARS-CoV-2 and small bowel

Transmissible gastroenteritis in neonatal dogs: experimental intestinal infection with transmissible gastroenteritis virus

Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals

Pathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes

Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in Golden Syrian hamster model: implications for disease pathogenesis and transmissibility

Pathogenesis and transmission of SARS-CoV-2 in Golden hamsters

Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies

Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

Evidence of infectivity of airborne porcine epidemic diarrhea virus and detection of airborne viral RNA at long distances from infected herds

Coronavirus survival on healthcare personal protective equipment

The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus

Survival of surrogate coronaviruses in water

Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections

Environmental sampling for respiratory pathogens in Jeddah airport during the 2013 Hajj season

Human coronavirus 229E remains infectious on common touch surface materials

Severe acute respiratory syndrome coronavirus on hospital surfaces

Stability and inactivation of SARS coronavirus

Environment and personal protective equipment tests for SARS-CoV-2 in the isolation room of an infant with infection

SARS-CoV-2 in wastewater: potential health risk, but also data source

Environmental contamination by SARS-DoV-2 in a designated hospital for coronavirus disease

Environmental contamination of SARS-CoV-2 in healthcare premises

Detection of severe acute respiratory syndrome coronavirus 2 RNA on surfaces in quarantine rooms

SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area

Symptomatic infection is associated with prolonged duration of viral shedding in mild coronavirus disease 2019: a retrospective study of 110 children in Wuhan

COVID-19) outbreak: what the department of endoscopy should know

Asociación Española de Gastroenterologia . Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18)

Overview of guidance for endoscopy during the coronavirus disease 2019 (COVID-19) pandemic

Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements)

Chapter of gastroenterologists professional guidance on risk mitigation for gastrointestinal endoscopy during COVID-19 pandemic in Singapore

COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies

Dig Endosc

Suggestions for infection prevention and control in digestive endoscopy during current 2019-nCoV pneumonia outbreak in Wuhan, Hubei province, China. Endoscopy

Epidemiological features and medical care-seeking process of patients with COVID-19 in Wuhan China

The difference in the incubation period of 2019 novel coronavirus (SARS-CoV-2) infection between travelers to Hubei and non-travelers: the need of a longer quarantine period

Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly

More data are required for incubation period, infectivity, and quarantine duration for COVID-19